Clinical Trial Update: Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the combination of niraparib and neratinib in advanced solid tumors with an expansion cohort in ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Niraparib (Niraparib)
• neratinib (neratinib)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Advanced Solid Tumor, Ovarian Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING